Approval · Notice of Compliance 7620 · 2005
CYCLESSA: Notice of Compliance 7620
Issued November 21, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7620
- Date
- November 21, 2005
- Company
- Organon Canada Inc.Kirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New presentation: 21 day package; change to new product monograph format
- Therapeutic class
- Oral contraceptive
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CYCLESSA | 02272903 | Marketed |
Medicinal ingredients
- DESOGESTREL 0.1 MG per TAB
- ETHINYL ESTRADIOL 0.025 MG per TAB
- DESOGESTREL 0.125 MG per TAB
- DESOGESTREL 0.15 MG per TAB